Global Hyaluronic Acid (HA) Raw Material Market: Size, Trends & Forecasts (2016-2020)
Scope of the Report
The report entitled “Global Hyaluronic Acid (HA) Raw Material Market: Size, Trends & Forecasts (2016-2020)”, provides analysis of the global HA raw material market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The report also provides the analysis of the global hyaluronic acid market, by value and by segments.
Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global HA raw material market has also been forecasted for the years 2016-2020, taking into consideration the previous growth pattern, the growth drivers and the current and future trends.
Bloomage Biotechnology Corporation, Allergan Plc and Valeant Pharmaceutical are some of the key companies directly or indirectly involved in hyaluronic acid raw material. The company profiling of these companies has been done in the report, which includes business overview, financial overview and respective business strategies of the companies.
Company Coverage
Hyaluronic acid is found in many parts of the human body and in animals. It is a naturally occurring substance and is found in eyes, joints, skin and rooster combs. Hyaluronic acid is also called Hyaluronan, Hyaluronate or HA.
The first hyaluronan biomedical product, Healon, was developed in the 1970s and 1980s by Pharmacia, and is approved for use in eye surgery. There are many uses of hyaluronic acid, such as in cancer, wound repair, skin management, cosmetic use, medical use, inflammation and others.
The hyaluronic acid raw material can be segmented on the basis of application and source. On the basis of application, the HA raw material can be divided into pharmaceutical segment, cosmetic segment and food segment. On the basis of source, the HA raw material can be divided into animal based source and non-animal based source.
The global hyaluronic acid raw material market is expected to increase at a significant growth rate during the forecasted period (2016-2020). The global hyaluronic acid raw material market is supported by various growth drivers, such as increase in the global healthcare products market, rising medical aesthetic procedures worldwide, increasing global obese population, aging population, etc. Yet, the market faces certain challenges, such as, less knowledge on long term effectiveness, side-effects of oral dose of HA, topical use of HA, etc.
The report entitled “Global Hyaluronic Acid (HA) Raw Material Market: Size, Trends & Forecasts (2016-2020)”, provides analysis of the global HA raw material market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The report also provides the analysis of the global hyaluronic acid market, by value and by segments.
Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global HA raw material market has also been forecasted for the years 2016-2020, taking into consideration the previous growth pattern, the growth drivers and the current and future trends.
Bloomage Biotechnology Corporation, Allergan Plc and Valeant Pharmaceutical are some of the key companies directly or indirectly involved in hyaluronic acid raw material. The company profiling of these companies has been done in the report, which includes business overview, financial overview and respective business strategies of the companies.
Company Coverage
- Bloomage Biotechnology Corporation
- Allergan Plc
- Valeant Pharmaceutical
Hyaluronic acid is found in many parts of the human body and in animals. It is a naturally occurring substance and is found in eyes, joints, skin and rooster combs. Hyaluronic acid is also called Hyaluronan, Hyaluronate or HA.
The first hyaluronan biomedical product, Healon, was developed in the 1970s and 1980s by Pharmacia, and is approved for use in eye surgery. There are many uses of hyaluronic acid, such as in cancer, wound repair, skin management, cosmetic use, medical use, inflammation and others.
The hyaluronic acid raw material can be segmented on the basis of application and source. On the basis of application, the HA raw material can be divided into pharmaceutical segment, cosmetic segment and food segment. On the basis of source, the HA raw material can be divided into animal based source and non-animal based source.
The global hyaluronic acid raw material market is expected to increase at a significant growth rate during the forecasted period (2016-2020). The global hyaluronic acid raw material market is supported by various growth drivers, such as increase in the global healthcare products market, rising medical aesthetic procedures worldwide, increasing global obese population, aging population, etc. Yet, the market faces certain challenges, such as, less knowledge on long term effectiveness, side-effects of oral dose of HA, topical use of HA, etc.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Hyaluronic Acid: An Overview
2.2 History of Hyaluronic Acid
2.3 Uses of Hyaluronic Acid
2.4 Hyaluronic Acid Raw Material by Segments
3. GLOBAL MARKET ANALYSIS
3.1 Global Hyaluronic Acid Market: An Analysis
3.1.1 Global Hyaluronic Acid Market by Value
3.1.2 Global Hyaluronic Acid by Segments
3.2 Global Hyaluronic Acid Raw Material Market: An Analysis
3.2.1 Global HA Raw Material Market by Volume
3.2.2 Global HA Raw Material Market Volume by Segments
3.2.3 Global HA Raw Material Market Value by Segments
3.3 Global Hyaluronic Acid Raw Material Market: Segment Analysis
3.3.1 Global HA Raw Material Pharmaceutical Segment Market by Volume
3.3.2 Global HA Raw Material Food Segment Market by Volume
3.3.3 Global HA Raw Material Cosmetic Segment Market by Volume
4. MARKET DYNAMICS
4.1 Growth Driver
4.1.1 Increase in the Global Healthcare Products Market
4.1.2 Rising Medical Aesthetic Procedures Worldwide
4.1.3 Increasing Global Obese Population
4.1.4 Aging Population
4.1.5 Increased Use in Orthopedics Market
4.2 Challenges
4.2.1 Long Term Effectiveness- Still not Known
4.2.2 Side-Effects of Oral Dose of HA
4.2.3 Topical Use of HA
4.3 Market Trends
4.3.1 HA Decreases by Age
4.3.2 Increasing Demand from Asia Pacific Region
4.3.3 Safest Form of HA
4.3.4 Source of HA Extraction
4.3.5 Food Grade Hyaluronic Acid
5. COMPETITIVE LANDSCAPE
5.1 Global HA Raw Material Segments Competition Overview
6. COMPANY PROFILING
6.1 Bloomage BioTechnology Corporation Limited
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategy
6.2 Allergan Plc
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategy
6.3 Valeant Pharmaceutical (Salix Pharmaceuticals)
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategy
2. INTRODUCTION
2.1 Hyaluronic Acid: An Overview
2.2 History of Hyaluronic Acid
2.3 Uses of Hyaluronic Acid
2.4 Hyaluronic Acid Raw Material by Segments
3. GLOBAL MARKET ANALYSIS
3.1 Global Hyaluronic Acid Market: An Analysis
3.1.1 Global Hyaluronic Acid Market by Value
3.1.2 Global Hyaluronic Acid by Segments
3.2 Global Hyaluronic Acid Raw Material Market: An Analysis
3.2.1 Global HA Raw Material Market by Volume
3.2.2 Global HA Raw Material Market Volume by Segments
3.2.3 Global HA Raw Material Market Value by Segments
3.3 Global Hyaluronic Acid Raw Material Market: Segment Analysis
3.3.1 Global HA Raw Material Pharmaceutical Segment Market by Volume
3.3.2 Global HA Raw Material Food Segment Market by Volume
3.3.3 Global HA Raw Material Cosmetic Segment Market by Volume
4. MARKET DYNAMICS
4.1 Growth Driver
4.1.1 Increase in the Global Healthcare Products Market
4.1.2 Rising Medical Aesthetic Procedures Worldwide
4.1.3 Increasing Global Obese Population
4.1.4 Aging Population
4.1.5 Increased Use in Orthopedics Market
4.2 Challenges
4.2.1 Long Term Effectiveness- Still not Known
4.2.2 Side-Effects of Oral Dose of HA
4.2.3 Topical Use of HA
4.3 Market Trends
4.3.1 HA Decreases by Age
4.3.2 Increasing Demand from Asia Pacific Region
4.3.3 Safest Form of HA
4.3.4 Source of HA Extraction
4.3.5 Food Grade Hyaluronic Acid
5. COMPETITIVE LANDSCAPE
5.1 Global HA Raw Material Segments Competition Overview
6. COMPANY PROFILING
6.1 Bloomage BioTechnology Corporation Limited
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategy
6.2 Allergan Plc
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategy
6.3 Valeant Pharmaceutical (Salix Pharmaceuticals)
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategy
LIST OF FIGURES
Figure 1: Uses of Hyaluronic Acid
Figure 2: Hyaluronic Acid Raw Material Segments
Figure 3: Global Hyaluronic Acid Market by Value; 2012-2015 (US$ Million)
Figure 4: Global Hyaluronic Acid Market by Value; 2016-2020 (US$ Million)
Figure 5: Global Hyaluronic Acid Market by Segments; 2015
Figure 6: Global HA Raw Material Market by Volume; 2010-2015 (Ton)
Figure 7: Global HA Raw Material Market by Volume; 2016-2020 (Ton)
Figure 8: Global HA Raw Material Market Volume by Segments; 2015-2020
Figure 9: Global HA Raw Material Market Value by Segments; 2015
Figure 10: Global HA Raw Material Pharmaceutical Segment by Volume; 2010-2015 (Ton)
Figure 11: Global HA Raw Material Pharmaceutical Segment by Volume; 2016-2020 (Ton)
Figure 12: Global HA Raw Material Food Segment by Volume; 2010-2015 (Ton)
Figure 13: Global HA Raw Material Food Segment by Volume; 2016-2020 (Ton)
Figure 14: Global HA Raw Material Cosmetic Segment by Volume; 2010-2015 (Ton)
Figure 15: Global HA Raw Material Cosmetic Segment by Volume; 2016-2020 (Ton)
Figure 16: Global Healthcare Products Market; 2014-2018 (US$ Billion)
Figure 17: Number of Medical Aesthetic Procedures and Number of Plastic Surgery Doctors by Country; 2015
Figure 18: Global Obese Population; 2006-2015 (Million)
Figure 19: Global Population Share above 50 Years of Age; 2010-2020
Figure 20: Global Orthopedics Market; 2014-2016 (US$ Billion)
Figure 21: Hyaluronic Acid Levels in the Human Body by Age
Figure 22: Bloomage Revenue; 2011-2015 (US$ Million)
Figure 23: Bloomage Revenue by Segments; 2015
Figure 24: Allergan Revenue; 2011-2015 (US$ Billion)
Figure 25:Allergan Revenue by Segments; 2015
Figure 26: Valeant Revenue; 2010-2015 (US$ Billion)
Figure 27: Valeant Revenue by Segments; 2015
Table 1: Hyaluronic Acid Segments Comparison
Table 2: Global HA Raw Material Segments Competition Overview
Table 3: Acquisitions of Valeant Pharmaceuticals
Figure 1: Uses of Hyaluronic Acid
Figure 2: Hyaluronic Acid Raw Material Segments
Figure 3: Global Hyaluronic Acid Market by Value; 2012-2015 (US$ Million)
Figure 4: Global Hyaluronic Acid Market by Value; 2016-2020 (US$ Million)
Figure 5: Global Hyaluronic Acid Market by Segments; 2015
Figure 6: Global HA Raw Material Market by Volume; 2010-2015 (Ton)
Figure 7: Global HA Raw Material Market by Volume; 2016-2020 (Ton)
Figure 8: Global HA Raw Material Market Volume by Segments; 2015-2020
Figure 9: Global HA Raw Material Market Value by Segments; 2015
Figure 10: Global HA Raw Material Pharmaceutical Segment by Volume; 2010-2015 (Ton)
Figure 11: Global HA Raw Material Pharmaceutical Segment by Volume; 2016-2020 (Ton)
Figure 12: Global HA Raw Material Food Segment by Volume; 2010-2015 (Ton)
Figure 13: Global HA Raw Material Food Segment by Volume; 2016-2020 (Ton)
Figure 14: Global HA Raw Material Cosmetic Segment by Volume; 2010-2015 (Ton)
Figure 15: Global HA Raw Material Cosmetic Segment by Volume; 2016-2020 (Ton)
Figure 16: Global Healthcare Products Market; 2014-2018 (US$ Billion)
Figure 17: Number of Medical Aesthetic Procedures and Number of Plastic Surgery Doctors by Country; 2015
Figure 18: Global Obese Population; 2006-2015 (Million)
Figure 19: Global Population Share above 50 Years of Age; 2010-2020
Figure 20: Global Orthopedics Market; 2014-2016 (US$ Billion)
Figure 21: Hyaluronic Acid Levels in the Human Body by Age
Figure 22: Bloomage Revenue; 2011-2015 (US$ Million)
Figure 23: Bloomage Revenue by Segments; 2015
Figure 24: Allergan Revenue; 2011-2015 (US$ Billion)
Figure 25:Allergan Revenue by Segments; 2015
Figure 26: Valeant Revenue; 2010-2015 (US$ Billion)
Figure 27: Valeant Revenue by Segments; 2015
Table 1: Hyaluronic Acid Segments Comparison
Table 2: Global HA Raw Material Segments Competition Overview
Table 3: Acquisitions of Valeant Pharmaceuticals
